Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Roy-Vallejo, E; De Córdoba-Oñate, SF; Delgado-Wicke, P; Triguero-Martínez, A; Montes, N; Carracedo-Rodríguez, R; Zurita-Cruz, N; Marcos-Jiménez, A; Lamana, A; Galván-Román, JM; García, GV; Zubiaur, P; Ciudad, M; Rabes, L; Sanz, M; Rodríguez, C; Villa, A; Rodríguez, JA; Marcos, C; Hernando, J; Diaz-Fernández, P; Abad, F; de los Santos, I; Serrano, DAR; Garcia-Vicuña, R; Fernández, CS; Gomariz, RP; Muñoz-Calleja, C; Fernández-Ruiz, E; González-Alvaro, I; Cardeñoso, L; PREDINMUN COVID Grp.

Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

Frontiers In Medicine. 2023; 10: Nº de citas: 2 [doi:10.3389/fmed.2023.1215246]

Calles A; Arregui M; Suárez-González J; García-Martos M; Márquez-Rodas I; Álvarez R; Martin M.

Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report.

Jco Precision Oncology. 2023; 7: Nº de citas: 2 [doi:10.1200/PO.23.00321]

Martínez-García, M; Olmos, P.

Handling Ill-Conditioned Omics Data With Deep Probabilistic Models

IEEE Journal of Biomedical and Health Informatics. 2023; 27(9): 4601-4610 Nº de citas: 1 [doi:10.1109/JBHI.2023.3279493]

Trneny, M; Avigdor, A; Mckinney, MS; Paneesha, S; Wahlin, BE; Hrom, JS; Cunningham, D; Morley, N; Canales, M; Bastos-Oreiro, M; Belada, D; Devizzi, L; Zheng, F; Demarini, DJ; Jiang, W; Jiang, P; Lynch, RC.

Parsaclisib, a PI3Kd inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study

Eclinicalmedicine. 2023; 63: Nº de citas: 4 [doi:10.1016/j.eclinm.2023.102130]

Vicente-Valor, J; Rodriguez-Gonzalez, C; Ferris-Villanueva, M; Chamorro-de-Vega, E; Romero-Jimenez, R; Gomez-Costas, D; Herrero-Bermejo, S; Tejerina-Picado, F; Osorio-Prendes, S; Oarbeascoa-Royuela, G; Herranz-Alonso, A; Sanjurjo-Saez, M.

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study

PHARMACOLOGICAL REPORTS. 2023; 75(5): 1254-1264 Nº de citas: 1 [doi:10.1007/s43440-023-00519-8]

Lobato, MPT; Navarro-Marchena, L; de Noriega, I; Olive, MM; Solano-Paez, P; Perez, ER; Colino, CG; Abos, MG; Garcia, MT; Labarga, BH; Rodriguez, RP; Ibor, BL; Lassaletta, A; Isaak, AM; Martinez, OC; Arrese, LV; Sales, AL; Subias, LG; Vega, CM; Moreno, L; Quiroga-Cantero, E.

Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; 26(3): 786-795 [doi:10.1007/s12094-023-03301-7]

Salmeron-Villalobos, J; Castrejon-de-Anta, N; Guerra-Garcia, P; Ramis-Zaldivar, JE; Lopez-Guerra, M; Mato, S; Colomer, D; Diaz-Crespo, F; Menarguez, J; Garrido-Pontnou, M; Andres, M; Garcia-Fernandez, E; Llavador, M; Frigola, G; Garcia, N; Gonzalez-Farre, B; Martin-Guerrero, I; Garrido-Colino, C; Astigarraga, I; Fernandez, A; Verdu-Amoros, J; Gonzalez-Muniz, S; Gonzaaez, B; Celis, V; Campo, E; Balague, O; Salaverria, I.

Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders

BLOOD. 2023; 142(5): 434-445 Nº de citas: 10 [doi:10.1182/blood.2022019543]

Pereira, MDM; Colombatti, R; Alvarez, F; Bartolucci, P; Bento, C; Brunetta, AL; Cela, E; Christou, S; Collado, A; de Montalembert, M; Dedeken, L; Fenaux, P; Galacteros, F; Glenthoj, A; Valle, VG; Kattamis, A; Kunz, J; Lobitz, S; McMahon, C; Pellegrini, M; Reidel, S; Russo, G; Freire, MS; van Beers, E; Kountouris, P; Gulbis, B.

Sickle cell disease landscape and challenges in the EU the ERN-EuroBloodNet perspective

Lancet Haematology. 2023; 10(8): 687-694 Nº de citas: 6 [doi:10.1016/S2352-3026(23)00182-5]

Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.

Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]

Hamadani, M; Coleman, M; Boccia, R; Duras, J; Hutchings, M; Zinzani, PL; Cordoba, R; Oreiro, MB; Williams, V; Liu, HQ; Stouffs, M; Langmuir, P; Sancho, JM.

Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL-102): A phase 1 study

HEMATOLOGICAL ONCOLOGY. 2023; 41(5): 848-857 [doi:10.1002/hon.3209]

Penas-Utrilla, D; Perez-Lago, L; Molero-Salinas, A; Estevez, A; Sanz, A; Herranz, M; Martinez-Laperche, C; Andres-Zayas, C; Veintimilla, C; Catalan, P; Alonso, R; Munoz, P; de Viedma, DG.

Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

Genome Medicine. 2023; 15(1): Nº de citas: 4 [doi:10.1186/s13073-023-01198-z]

Gavriilaki, E; Sakellari, I; Labopin, M; Bornhauser, M; Hamladji, RM; Casper, J; Edinger, M; Zak, P; Yakoub-Agha, I; Ciceri, F; Schroeder, T; Zuckerman, T; Kobbe, G; Yeshurun, M; Narni, F; Finke, J; Diez-Martin, JL; Berceanu, A; Hilgendorf, I; Verbeek, M; Olivieri, A; Savani, B; Spyridonidis, A; Nagler, A; Mohty, M.

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

BONE MARROW TRANSPLANTATION. 2023; 58(10): 1084-1088 Nº de citas: 4 [doi:10.1038/s41409-023-02028-x]

Solano, C; Castro-Rebollo, P; Perez-Martinez, A; López-Corral, L; Barba-Suñol, P; Kwon, M; Ortiz, V; Sanz-Caballer, J; Caballero, AC; Martinez, J; Cedillo, A; Sureda, A.

Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study

BMJ Open. 2023; 13(7): Nº de citas: 2 [doi:10.1136/bmjopen-2022-071371]

Gazeau, N; Liang, EC; Wu, Q; Voutsinas, JM; Barba, P; Iacoboni, G; Kwon, M; Ortega, JLR; Lopez-Corral, L; Hernani, R; Ortiz-Maldonado, V; Martinez-Cibrian, N; Martinez, AP; Maziarz, RT; Williamson, S; Nemecek, ER; Shadman, M; Cowan, AJ; Green, DJ; Kimble, E; Hirayama, AV; Maloney, DG; Turtle, CJ; Gauthier, J.

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Transplantation And Cellular Therapy. 2023; 29(7): 430-437 Nº de citas: 80 [doi:10.1016/j.jtct.2023.04.001]

Bastos-Oreiro, M; Sanz-Villanueva, L; Muniz, P; Bailen, R; Chicano, M; Oarbeskoa, G; Gomez, I; Gutierrez, A; de la Iglesia, I; Carbonell, D; Diaz-Crespo, FJ; Menarguez, J; Diez-Martin, JL; Kwon, M; Buno, I; Martinez-Laperche, C.

Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma

Transplantation And Cellular Therapy. 2023; 29(7): 4721-4724 Nº de citas: 3 [doi:10.1016/j.jtct.2023.03.009]

Muntanola, A; Villalobos, MT; Gonzalez-Villambrosia, S; Rodriguez-Salazar, MJ; Jimenez-Ubieto, A; Bastidas-Mora, G; Cordoba, R; Infante, M; Vidal, MJ; Diaz, FJ; Baile, M; Bastos-Oreiro, M; Panizo, C; Sancho, JM; Navarro, B; Garcia, T; Escoda, L; Abrisqueta, P; Terol, MJ; de Campo, R; Mozas, P; Lopez-Guillermo, A; Salar, A; Montalban, C.

Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study

BRITISH JOURNAL OF HAEMATOLOGY. 2023; 202(4): 776-784 [doi:10.1111/bjh.18912]

Jimenez-Ubieto, A; Martin-Munoz, A; Poza, M; Dorado, S; Garcia-Ortiz, A; Revilla, E; Sarandeses, P; Ruiz-Heredia, Y; Baumann, T; Rodriguez, A; Calbacho, M; Sanchez, PM; Pina, JMS; Garcia-Sancho, AM; Figaredo, G; Rufian, L; Rodriguez, M; Carneros, L; Martinez-Laperche, C; Bastos-Oreiro, M; Wang, CW; Cedena, MT; Rapado, I; de Toledo, P; Valeri, A; Ayala, R; Martinez-Lopez, J; Barrio, S.

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Frontiers in Immunology. 2023; 14: Nº de citas: 6 [doi:10.3389/fimmu.2023.1188818]

Azanza, JR; Mensa, J; Barberan, J; Vazquez, L; de Oteyza, JP; Kwon, M; Yanez, L; Aguado, JM; Gracian, AC; Solano, C; Camps, IR; Fortun, J; Lleti, MS; Gudiol, C; Rubio, TO; Garcia-Vidal, C; Tarrats, MR; Grande, MSL; Gonzalez-Sierra, P; Gutierrez, CD.

Recommendations on the use of azole antifungals in hematology-oncology patients

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(3): 236-258 Nº de citas: 21 [doi:10.37201/req/013.2023]